We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-15.27%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$72.6M
AUM Growth
+$36.2M
Cap. Flow
+$39.4M
Cap. Flow %
54.35%
Top 10 Hldgs %
38.26%
Holding
170
New
94
Increased
8
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
ETP
Energy Transfer Partners L.p.
ETP
+$3.55M
2
ETP
Energy Transfer Partners, L.P.
ETP
+$3.01M
3
WPZ
Williams Partners L.P.
WPZ
+$2.75M
4
MPLX icon
MPLX
MPLX
+$2.63M
5
BPL
Buckeye Partners, L.P.
BPL
+$1.73M

Top Sells

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$656K
2
SRE icon
Sempra
SRE
+$284K
3
DTE icon
DTE Energy
DTE
+$260K
4
SE
Spectra Energy Corp Wi
SE
+$258K
5
EIX icon
Edison International
EIX
+$242K

Sector Composition

Rank Sector Weight
1 Energy 48.57%
2 Healthcare 38.33%
3 Utilities 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TCRT icon
76
Alaunos Therapeutics
TCRT
$4.74M
$215K 0.3%
+193
New +$198K
RGLS
77
DELISTED
Regulus Therapeutics
RGLS
$212K 0.29%
+254
New +$202K
ACAD icon
78
Acadia Pharmaceuticals
ACAD
$4.25B
$206K 0.28%
7,357
-457
-6% -$9.96K
TGTX icon
79
TG Therapeutics
TGTX
$8.58B
$204K 0.28%
+23,986
New +$210K
JUNO
80
DELISTED
Juno Therapeutics, Inc.
JUNO
$204K 0.28%
+5,353
New +$187K
LJPC
81
DELISTED
La Jolla Pharmaceutical Company
LJPC
$202K 0.28%
9,645
-605
-6% -$10.8K
AGIO icon
82
Agios Pharmaceuticals
AGIO
$2.16B
$201K 0.28%
+4,954
New +$212K
EPZM
83
DELISTED
Epizyme, Inc
EPZM
$199K 0.27%
+16,400
New +$166K
TRVN
84
DELISTED
Trevena, Inc.
TRVN
$198K 0.27%
38
-3
-7% -$15.1K
ACHN
85
DELISTED
Achillion Pharmaceuticals
ACHN
$198K 0.27%
+25,711
New +$188K
ICPT
86
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$197K 0.27%
+1,535
New +$181K
ARRY
87
DELISTED
Array Biopharma Inc
ARRY
$196K 0.27%
+66,376
New +$199K
USO icon
88
United States Oil Fund
USO
$2.45B
$194K 0.27%
+2,500
New +$187K
ENLC
89
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$194K 0.27%
+17,251
New +$185K
SRNE
90
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$194K 0.27%
+36,130
New +$210K
AKBA icon
91
Akebia Therapeutics
AKBA
$327M
$193K 0.27%
+21,430
New +$174K
BPMC
92
DELISTED
Blueprint Medicines
BPMC
$189K 0.26%
+10,484
New +$182K
DVAX
93
DELISTED
Dynavax Technologies
DVAX
$188K 0.26%
9,768
-612
-6% -$12.4K
NBIX icon
94
Neurocrine Biosciences
NBIX
$17.7B
$188K 0.26%
+4,760
New +$189K
INSM icon
95
Insmed
INSM
$23.2B
$187K 0.26%
14,788
-928
-6% -$12.2K
ESPR
96
DELISTED
Esperion Therapeutics
ESPR
$186K 0.26%
+11,011
New +$177K
AIMT
97
DELISTED
Aimmune Therapeutics
AIMT
$185K 0.25%
+13,666
New +$213K
BLUE
98
DELISTED
bluebird bio
BLUE
$181K 0.25%
+328
New +$201K
KITE
99
DELISTED
Kite Pharma, Inc.
KITE
$181K 0.25%
+3,940
New +$191K
INFI
100
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$179K 0.25%
+34,021
New +$208K
2 3
4
5 6

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q1 2016 Portfolio in Review

As of Q1 2016, Virtus ETF Advisers held 170 positions worth $72.6M, up 99% from $36.4M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Virtus ETF Advisers deployed $39.4M of net new capital in Q1 2016, opening 94 new positions and adding to 8 existing holdings. Its largest new stake was Energy Transfer Partners L.p.: 127,467 shares worth $4.12M.

By sector, the portfolio is most concentrated in Energy at 49% of assets, up from 27% a quarter earlier, followed by Healthcare and Utilities.

On the sell side, the largest reduction was Spectra Energy Corp Wi, an estimated $258K trimmed.

  • Virtus ETF Advisers's largest Q1 2016 buy was Energy Transfer Partners L.p.: 127,467 shares worth $4.12M.
  • Virtus ETF Advisers added most to Buckeye Partners, L.P. in Q1 2016, an estimated $1.73M increase.
  • Virtus ETF Advisers's biggest Q1 2016 reduction was Spectra Energy Corp Wi, cutting an estimated $258K.
  • Virtus ETF Advisers fully exited Aegerion Pharmaceuticals in Q1 2016, selling an estimated $656K.
  • Virtus ETF Advisers's ten largest holdings make up 38% of its $72.6M portfolio in Q1 2016.
  • Virtus ETF Advisers opened 94 new positions and closed 17 in Q1 2016.
  • Virtus ETF Advisers's portfolio value rose 99% quarter-over-quarter to $72.6M.

Based on Virtus ETF Advisers's 13F filing for Q1 2016, filed 16 May 2016.